A Novel Deep Eutectic System for the Creation of New Co crystals
EUTOMIC presents a completely new and unexpected idea sprung from the cradle of the EU Horizon2020 FET-Open grant ‘MagnaPharm’ which is concerned with the control of polymorphism in pharmaceuticals through the application of stron...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto Eutomic
Duración del proyecto: 18 meses
Fecha Inicio: 2020-05-05
Fecha Fin: 2021-11-30
Líder del proyecto
UNIVERSITY OF BRISTOL
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
100K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
EUTOMIC presents a completely new and unexpected idea sprung from the cradle of the EU Horizon2020 FET-Open grant ‘MagnaPharm’ which is concerned with the control of polymorphism in pharmaceuticals through the application of strong magnetic fields. The desire to control and constrain the growth of crystals using external stimuli in MagnaPharm led inexorably to the discovery of this new class of deep eutectics, using a sparingly stable synergistic solvent system as a vector for the spontaneous creation of new cocrystals in and of itself.
EUTOMIC proposes the support of the FET Innovation Launchpad to increase the investment readiness of this innovation towards a commercially attractive & sustainable university spin-off company, ‘Eutomic Ltd.’, EUTOMIC will foster the full exploration and exploitation of the novel materials being created from this new eutectic system.